每經AI快(kuai)訊，雪榕生物公(gong)告，公(gong)司(si)(si)控(kong)(kong)股(gu)股(gu)東(dong)、實際控(kong)(kong)制(zhi)(zhi)人(ren)楊勇(yong)萍與上海萬(wan)(wan)紫(zi)千(qian)鴻智(zhi)能科技(ji)有限公(gong)司(si)(si)簽署(shu)了控(kong)(kong)制(zhi)(zhi)權變(bian)更(geng)框架協(xie)議(yi)，約定由楊勇(yong)萍及(ji)其一致行動人(ren)將(jiang)部(bu)分(fen)(fen)股(gu)份(fen)轉讓(rang)給(gei)萬(wan)(wan)紫(zi)千(qian)鴻、楊勇(yong)萍剩余全部(bu)股(gu)份(fen)表決權委托(tuo)給(gei)萬(wan)(wan)紫(zi)千(qian)鴻及(ji)萬(wan)(wan)紫(zi)千(qian)鴻現金認購公(gong)司(si)(si)向特定對(dui)象(xiang)發(fa)行的(de)新股(gu)三部(bu)分(fen)(fen)組成。協(xie)議(yi)生效后，公(gong)司(si)(si)的(de)控(kong)(kong)股(gu)股(gu)東(dong)將(jiang)變(bian)更(geng)為萬(wan)(wan)紫(zi)千(qian)鴻，實際控(kong)(kong)制(zhi)(zhi)人(ren)將(jiang)變(bian)更(geng)為蔣智(zhi)。公(gong)司(si)(si)股(gu)票及(ji)可轉換公(gong)司(si)(si)債券(quan)自2025年3月13日開(kai)市起復牌。